Damora Therapeutics Inc (DMRA)

May 01, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeat

May 01, 2026

May 01, 2026

Two new Damora hires get stock options for 57,500 shares - Stock Titan

May 01, 2026

May 01, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026

May 01, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Institutional Ownership 2026 - MarketBeat

May 01, 2026

Apr 30, 2026

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

Apr 30, 2026

Apr 29, 2026

Damora Therapeutics (NASDAQ: DMRA) sets 2026 virtual meeting, director votes and say-on-pay - Stock Titan

Apr 29, 2026

Apr 28, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Chart and Price History 2026 - MarketBeat

Apr 28, 2026

Apr 25, 2026

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Upgraded at Royal Bank Of Canada - MarketBeat

Apr 25, 2026

Apr 24, 2026

DMRA Initiated Coverage by RBC Capital -- Price Target Set at $4 - GuruFocus

Apr 24, 2026

Apr 24, 2026

Royal Bank Of Canada Begins Coverage on Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) - MarketBeat

Apr 24, 2026

Apr 24, 2026

RBC Initiates Damora Therapeutics at Outperform, Speculative Risk With $40 Price Target - marketscreener.com

Apr 24, 2026

Apr 23, 2026

Paramora Holding LLC owns 2,045,473 shares — Damora (NASDAQ: DMRA) - Stock Titan

Apr 23, 2026

Apr 23, 2026

RBC initiates Damora Therapeutics stock at Outperform, $40 target By Investing.com - Investing.com South Africa

Apr 23, 2026

Apr 23, 2026

RBC initiates Damora Therapeutics stock at Outperform, $40 target - Investing.com UK

Apr 23, 2026

Apr 23, 2026

Damora Therapeutics Inc (DMRA) Stock Price & 30 Year Financial Data - GuruFocus

Apr 23, 2026

Apr 23, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) 10K Form and Latest SEC Filings 2026 - MarketBeat

Apr 23, 2026

Apr 21, 2026

DMRA Price History for Damora Therapeutics Stock - Barchart.com

Apr 21, 2026

Apr 20, 2026

Damora Therapeutics (NASDAQ: DMRA) replaces EY Denmark with EY US - Stock Titan

Apr 20, 2026

Apr 16, 2026

Klein Hersh Places President and CEO for Damora Therapeutics - Hunt Scanlon Media

Apr 16, 2026

Apr 15, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Forecast and Price Target 2026 - MarketBeat

Apr 15, 2026

Apr 15, 2026

Damora (DMRA) Stock: Hold Signals (Trend Weakens) 2026-04-15Volume Leaders - Newser

Apr 15, 2026

Apr 13, 2026

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Short Interest Update - MarketBeat

Apr 13, 2026

Apr 11, 2026

Certain Warrants of Galecto, Inc. are subject to a Lock-Up Agreement Ending on 12-APR-2026. - marketscreener.com

Apr 11, 2026

Apr 11, 2026

Certain Stock Options of Galecto, Inc. are subject to a Lock-Up Agreement Ending on 12-APR-2026. - marketscreener.com

Apr 11, 2026

Apr 11, 2026

Certain Common Stock of Galecto, Inc. are subject to a Lock-Up Agreement Ending on 12-APR-2026. - marketscreener.com

Apr 11, 2026

Apr 11, 2026

Is Damora Therapeutics’ (DMRA) New CEO and Fast Track Status Reframing Its Pipeline Execution Story? - Sahm

Apr 11, 2026

Apr 10, 2026

Damora Therapeutics Inc (DMRA) Stock Earnings Transcripts - GuruFocus

Apr 10, 2026

Apr 09, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Financials 2026Income Statement and Balance Sheet - MarketBeat

Apr 09, 2026

Apr 09, 2026

Will Damora (DMRA) Stock Go Higher | Price at $25.70, Up 0.39%Strong Buy Rating - Newser

Apr 09, 2026

Apr 06, 2026

Is Damora (DMRA) Stock Consolidating | Price at $24.57, Down 2.07%Risk Analysis - Newser

Apr 06, 2026

Apr 03, 2026

Spyre Therapeutics Announces Grants of Inducement Awards - marketscreener.com

Apr 03, 2026